KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Current Assets (2016 - 2025)

Globus Medical's Current Assets history spans 15 years, with the latest figure at $2.1 billion for Q4 2025.

  • For Q4 2025, Current Assets fell 2.37% year-over-year to $2.1 billion; the TTM value through Dec 2025 reached $2.1 billion, down 2.37%, while the annual FY2025 figure was $2.1 billion, 2.37% down from the prior year.
  • Current Assets reached $2.1 billion in Q4 2025 per GMED's latest filing, up from $1.9 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $2.2 billion in Q4 2024 to a low of $814.4 million in Q1 2021.
  • Average Current Assets over 5 years is $1.4 billion, with a median of $1.5 billion recorded in 2023.
  • Peak YoY movement for Current Assets: surged 108.41% in 2023, then dropped 10.08% in 2025.
  • A 5-year view of Current Assets shows it stood at $864.5 million in 2021, then increased by 13.75% to $983.3 million in 2022, then surged by 94.78% to $1.9 billion in 2023, then rose by 13.67% to $2.2 billion in 2024, then decreased by 2.37% to $2.1 billion in 2025.
  • Per Business Quant, the three most recent readings for GMED's Current Assets are $2.1 billion (Q4 2025), $1.9 billion (Q3 2025), and $1.7 billion (Q2 2025).